FELYCIN
LIVE

Serial Number

90874483

Owner

Triviumvet DAC

Attorney

Sean P. McMahon

Filing Date

Aug 10, 2021

Add to watchlist:

No watchlists yet
View on USPTO

FELYCIN Trademark

Serial Number: 90874483 • Registration: 6977126

FELYCIN is a trademark filed by Triviumvet DAC on August 10, 2021. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Triviumvet DAC (9 trademarks)

Unit 3A Cleaboy Business Park
Waterford X91H5FE , IE

Entity Type: 99

Trademark Details

Filing Date

August 10, 2021

Registration Date

February 14, 2023

Published for Opposition

November 29, 2022

Goods & Services

research and development services in the field of cardiac disorders and age related illnesses; scientific research services for others in the field of cardiac disorders and age related illnesses; research in the field of new products for animals; product testing; product safety and product quality testing; research and testing services in the field of veterinary drugs; services for assessing the efficacy of human drugs for animals, namely, veterinary drug discovery services; services for assessing the efficacy of veterinary drugs, namely, pharmaceutical veterinary drug discovery services; provision of information relating to veterinary research and product development; providing a website featuring data relating to veterinary research and development

veterinary preparations and substances, namely, gastroprotectants, pain relief medication, diagnostic preparations for veterinary use and purposes and veterinary preparations for companion animals for the treatment of age related diseases; veterinary preparations for companion animals for the treatment and prevention of cardiac disorders and age related illnesses; veterinary substances, namely, immunosuppressants for veterinary use and animal appropriate preparations for veterinary use for the treatment of metabolic diseases and disorders, oncological diseases and disorders, dermatological diseases and disorders, hormonal diseases and disorders, viral diseases and disorders, bacterial diseases and disorders, infectious diseases and disorders, viral diseases and disorder, as well as diseases and disorders of the alimentary tract, cardiovascular system, musculoskeletal system, central nervous system, peripheral nervous system, genitourinary system, and respiratory system; pharmaceutical preparations for veterinary use for the treatment and prevention of cardiac disorders and age related illnesses; pharmaceutical products for veterinary use for the treatment and prevention of cardiac disorders and age related illnesses; chemical reagent preparations for veterinary use; veterinary medicines for the treatment of cardiac disorders and age related illnesses; veterinary vaccines

Filing History

TEAS CHANGE OF CORRESPONDENCE RECEIVED
Dec 8, 2025 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Dec 8, 2025 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Dec 8, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Dec 8, 2025 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Dec 8, 2025 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Dec 8, 2025 COAR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Feb 14, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
Feb 14, 2023 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 29, 2022 NPUB
PUBLISHED FOR OPPOSITION
Nov 29, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 9, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 26, 2022 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 29, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 29, 2022 CRFA
ASSIGNED TO LIE
Sep 29, 2022 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 19, 2022 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 5, 2022 GNRN
NON-FINAL ACTION E-MAILED
May 5, 2022 GNRT
NON-FINAL ACTION WRITTEN
May 5, 2022 CNRT
ASSIGNED TO EXAMINER
May 3, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 1, 2021 NWOS
NEW APPLICATION ENTERED
Aug 13, 2021 NWAP